Times Square Capital Management, LLC Merus N.V. Transaction History
Times Square Capital Management, LLC
- $6.49 Billion
- Q3 2024
A detailed history of Times Square Capital Management, LLC transactions in Merus N.V. stock. As of the latest transaction made, Times Square Capital Management, LLC holds 272,435 shares of MRUS stock, worth $12.7 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
272,435
Previous 182,220
49.51%
Holding current value
$12.7 Million
Previous $10.8 Million
26.24%
% of portfolio
0.21%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
61.9MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$194 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$159 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$156 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$135 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$122 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.14B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...